The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis

Cardiovasc Drugs Ther. 2023 Aug;37(4):621-622. doi: 10.1007/s10557-022-07408-x. Epub 2022 Nov 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / chemically induced
  • Arthritis, Rheumatoid* / diagnosis
  • Arthritis, Rheumatoid* / drug therapy
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / epidemiology
  • Humans
  • Hydroxychloroquine / adverse effects

Substances

  • Hydroxychloroquine
  • Antirheumatic Agents